Niniek Burhan, H. P. Brahmantyo, Djoko Heri Hermanto, P. Arsana
{"title":"Clinical Response of Convalescent Plasma Therapy in COVID-19 Patients in Dr. Saiful Anwar General Hospital","authors":"Niniek Burhan, H. P. Brahmantyo, Djoko Heri Hermanto, P. Arsana","doi":"10.21776/ub.jkb.2021.031.04.5","DOIUrl":null,"url":null,"abstract":"The use of convalescent plasma has been beneficial for more than a century to treat various infections. The lack of effective treatment currently available for COVID-19 has reemerged the use of convalescent plasma as a potential therapeutic option. This is an observational descriptive study in 13 COVID-19 patient who got convalescent Plasma. Consist of 11 (84%) male patient, 2 (16%) female patient. Divided into two groups based on severity, and outcome. 38% patient included in severe disesase and 62% patient in critically Ill condition. 30% patient who got convalescent plasma deceased, and 70% had a resolve condition.","PeriodicalId":17705,"journal":{"name":"Jurnal Kedokteran Brawijaya","volume":"6 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jurnal Kedokteran Brawijaya","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21776/ub.jkb.2021.031.04.5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The use of convalescent plasma has been beneficial for more than a century to treat various infections. The lack of effective treatment currently available for COVID-19 has reemerged the use of convalescent plasma as a potential therapeutic option. This is an observational descriptive study in 13 COVID-19 patient who got convalescent Plasma. Consist of 11 (84%) male patient, 2 (16%) female patient. Divided into two groups based on severity, and outcome. 38% patient included in severe disesase and 62% patient in critically Ill condition. 30% patient who got convalescent plasma deceased, and 70% had a resolve condition.